Skip to content

Uterine Myoma Case Study

1. Sparic R. Uterine myomas in pregnancy, childbirth and the puerperium. Srp Arh Celok Lek. 2014;142(1-2):118–124.[PubMed]

2. Downes E, Sikirica V, Gilabert-Estelles J, Bolge SC, Dodd SL, Maroulis C, et al. The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol. 2010;152(1):96–102.[PubMed]

3. Sparic R, Hudelist G, Berisavac M, Gudovic A, Buzadzic S. Hysterectomy throughout history. Acta Chir Iugosl. 2011;58(4):9–14.[PubMed]

4. Fleischer R, Weston GC, Vollenhoven BJ, Rogers PA. Pathophysiology of fibroid disease: angiogenesis and regulation of smooth muscle proliferation. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):603–614.[PubMed]

5. Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):571–588.[PubMed]

6. Tinelli A, Malvasi A, Rahimi S, Negro R, Cavallotti C, Vergara D, et al. Myoma pseudocapsule: a distinct endocrinoanatomical entity in gynecological surgery. Gynecol Endocrinol. 2009;25(10):661–667.[PubMed]

7. Tinelli A, Hurst BS, Hudelist G, Tsin DA, Stark M, Mettler L, et al. Laparoscopic myomectomy focusing on the myoma pseudocapsule: technical and outcome reports. Hum Reprod. 2012;27(2):427–435.[PubMed]

8. Evans P, Brunsell S. Uterine fibroid tumors: diagnosis and treatment. Am Fam Physician. 2007;75(10):1503–1508.[PubMed]

9. Somigliana E, Vercellini P, Daguati R, Pasin R, De Giorgi O, Crosignani PG. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update. 2007;13(5):465–476.[PubMed]

10. Wise LA, Laughlin-Tommaso SK. Uterine leiomyomata. In: Goldman MB, Troisi R, Rexrode KM, editors. Women and Health. San Diego: Academic Press; 2013. pp. 285–306.

11. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94(4):435–438.[PubMed]

12. Wise LA, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL, et al. Reproductive factors, hormonal contraception and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol. 2004;159(2):113–123.[PMC free article][PubMed]

13. Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol. 2009;113(3):630–635.[PMC free article][PubMed]

14. Wise LA, Ruiz-Narvaez EA, Palmer JR, Cozier YC, Tandon A, Patterson N, et al. African ancestry and genetic risk for uterine leiomyomata. Am J Epidemiol. 2012;176(12):1159–1168.[PMC free article][PubMed]

15. Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004;104(2):396–406.[PubMed]

16. Othman EE, Al-Hendy A. Molecular genetics and racial disparities of uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):589–601.[PMC free article][PubMed]

17. Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007;87(4):725–736.[PubMed]

18. Duhan N. Current and emerging treatments of uterine myoma- an update. Int J Womens Health. 2011;3:231–241.[PMC free article][PubMed]

19. Gupta S, Jose J, Manyonda I. Clinical presentation of fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):615–626.[PubMed]

20. Jacoby VL, Fujimoto VY, Giudice LC, Kupperman M, Washington AE. Racial and ethnic disparities in benign gynecologic conditions and associated surgeries. Am J Obsets Gynecol. 2010;202(6):514–521.[PMC free article][PubMed]

21. Wise LA, Radin RG, Palmer JR, Kumanyika SK, Boggs DA, Rosenberg L. Intake of fruit, vegetables, and carotenoids in relation to risk of uterine leiomyomata. Am J Clin Nutr. 2011;94(6):1620–1631.[PMC free article][PubMed]

22. Wise LA, Radin RG, Palmer JR, Kumanyika SK, Rosenberg L. A prospective study of dairy intake and the risk of uterine leiomyomata. Am J Epidemiol. 2010;171(2):221–232.[PMC free article][PubMed]

23. Wise LA, Radin RG, Kumanyika SK, Ruiz-Navarez EA, Palmer JR, Rosenberg L. Prospective study of dietary fat and risk of uterine leiomyomata. Am J Clin Nutr. 2014;99(5):1105–1116.[PMC free article][PubMed]

24. Wise LA, Palmer JR, Ruiz-Navarez E, Reich DE, Rosenberg L. Is the observed association between dairy intake and fibroids in African Americans explained by genetic ancestry? Am J Epidemiol. 2013;178(7):1114–1119.[PMC free article][PubMed]

25. Wise LA, Palmer JR, Spiegelman D, Harlow BL, Stewart EA, Adams-Campbell LL, et al. Influence on body size and body fat distribution on the risk of uterine leiomyomata in U.S.Black Women. Epidemiology. 2005;16(3):346–354.[PMC free article][PubMed]

26. Uimari O, Suomalainen-Konig S, Sakkinen N, Santala M, Nieminen P, Ryynanen M. Natural history of familial myomas. Eur J Obstet Gynecol Reprod Biol. 2006;125(2):255–258.[PubMed]

27. Luoto R, Kaprio J, Rutanen EM, Taipale P, Perola M, Koskenvuo M. Heritabilty and risk factors of uterine fibroidsthe Finnish twin Cohort study. Maturitas. 2000;37(1):15–26.[PubMed]

28. Bulun SE. Uterine fibroids. N Engl J Med. 2013;369(14):1344–1355.[PubMed]

29. Mäkinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011;334(6053):252–255.[PubMed]

30. Eggert SL, Huyck KL, Somasundaram P, Kavalla R, Stewart EA, Lu AT, et al. Genome-vide linkage and association analyses implicate FASN in predisposition to uterine leiomyomata. Am J Hum Genet. 2012;91(4):621–628.[PMC free article][PubMed]

31. Cha PC, Takahashi A, Hosono N, Low SK, Kamatani N, Kubo M, et al. A genome-wide association study identifies three loci associated with susceptibilty to uterine fibroids. Nat Genet. 2011;43(5):447–450.[PubMed]

32. Edwards TL, Michels KA, Hartmann KE, Velez Edwards DR. BET1L and TNRC6B associated with uterine fibroid risk among European Americans. Hum Genet. 2013;132(8):943–953.[PMC free article][PubMed]

33. Terry KL, De Vivo I, Hankinson SE, Missmer SA. Reproductive characteristics and risk of uterine leiomyomata. Fertil Steril. 2010;94(7):2703–2707.[PMC free article][PubMed]

34. Lee HJ, Norwitz ER, Shaw J. Contemporary management of fibroids in pregnancy. Rev Obstet Gynecol. 2010;3(1):20–27.[PMC free article][PubMed]

35. De Vivo A, Mancuso A, Giacobbe A, Savasta LM, De Dominici R, Dugo N, et al. Uterine myomas during pregnancy: a longitudinal sonographic study. Ultrasound Obstet Gynecol. 2011;37(3):361–365.[PubMed]

36. Levy BS. Modern management of uterine fibroids. Acta Obstet Gynecol Scand. 2008;87(8):812–823.[PubMed]

37. Baird DD, Travlos G, Wilson R, Dunson DB, Hill MC, D’Alisio AA, et al. Uterine leiomyomata in relation to insulin- like growth factor-I, insulin and diabetes. Epidemiology. 2009;20(4):604–610.[PMC free article][PubMed]

Case Study: Obstetrics and Gynecology

Embolization to Treat Uterine Fibroids with Bleeding and Severe Anemia

A 45-year old female Jehovah’s Witness patient with a history of uterine fibroids and severe menorrhagia presented with shortness of breath, fatigue and weakness. She also had a history of deep venous thrombosis (DVT) and pulmonary emboli (PE). She was admitted with iron-deficient anemia for workup and treatment. 

After a Hematology consult, the Coumadin she had been taking for her DVT/PE history was discontinued. Gynecology was consulted and she was diagnosed with multiple large fibroids after a transvaginal ultrasound examination. It was determined that a hysterectomy may be needed, but her 3.8 g/dL hemoglobin level upon admission was too low for surgery. She was started on Lupron (Leuprolide acetate), a long acting (depot) injection medication that suppresses secretion of the gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and is thereby helpful in cessation of hemorrhage from uterine fibroids. She was also started on daily, intravenous 200 mg iron sucrose, and was given darbepoetin alpha 25 mcg intravenously weekly. After 3 weeks her hemoglobin level was 5.5 g/dL and she was sent home on monthly Lupron injections and oral iron supplements. She was also followed in our Hematology clinic.

Four months later she was admitted again with shortness of breath, fatigue and weakness, this time with a hemoglobin level of 3.8 g/dL. She had missed one treatment in her Lupron regimen, and had started to bleed again. Her ferritin level was 9 ng/mL (normal level for women being 18-160). On her third hospital day she was taken to interventional radiology for a uterine artery fibroid embolization. Two days later she was discharged with a hemoglobin level of 4.9 on oral iron sulfate, 325 mg twice a day. One month later on a follow up visit in the Hematology Clinic her hemoglobin level was 8.0 and she is now off of Lupron and continuing her oral iron supplements.